Evidence map›Paper›PMID 38732450›Full record

ReviewPlants (Basel, Switzerland)2024

Echinacea: Bioactive Compounds and Agronomy.

Fatemeh Ahmadi, Khalil Kariman, Milad Mousavi, Zed Rengel

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Immune system evaluation of Echinacea Purpurea root extract in female Harlan Sprague Dawley (Hsd:Sprague Dawley SD) rats.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Fabrication and Characterization of Electrospun Keratin Mats withInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Plants (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatemeh AhmadiUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-8984-3930
Khalil KarimanUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, Australia.
Milad MousaviUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, Australia.
Zed RengelUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0003-3433-161X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For centuries, medicinal plants have been used as sources of remedies and treatments for various disorders and diseases. Recently, there has been renewed interest in these plants due to their potential pharmaceutical properties, offering natural alternatives to synthetic drugs. Echinacea, among the world's most important medicinal plants, possesses immunological, antibacterial, antifungal, and antiviral properties. Nevertheless, there is a notable lack of thorough information regarding the echinacea species, underscoring the vital need for a comprehensive review paper to consolidate existing knowledge. The current review provides a thorough analysis of the existing knowledge on recent advances in understanding the physiology, secondary metabolites, agronomy, and ecology of echinacea plants, focusing on

Indexed as

abiotic stresshydroponicsmedicinal plantssecondary metabolites

Identifiers

PMID38732450
PMCPMC11085449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.